How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Immunotherapy and targeted therapy combinations in metastatic breast cancer - The Lancet Oncology
In vitro functional assays to augment immunotherapy research
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Modelling the tumor immune microenvironment for precision immunotherapy - Mackenzie - 2022 - Clinical & Translational Immunology - Wiley Online Library
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
Frontiers In vivo Imaging Technologies to Monitor the Immune System
CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
